We are live on
!
Find out more
AAM
Augustine Asset Management Portfolio holdings
AUM
$494M
1-Year Est. Return
76.22%
This Fund
S&P 500
This Quarter
Est. Return
-12.07%
1 Year Est. Return
+76.22%
3 Year Est. Return
+343.91%
5 Year Est. Return
+411.93%
10 Year Est. Return
+1,097.1%
AUM
$146M
AUM Growth
-$34.3M
(-19%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-6.95%
Top 10 Holdings %
Top 10 Hldgs %
42.79%
Holding
83
New
8
Increased
12
Reduced
39
Closed
8
Avg Time Held
9.5
quarters
Top 10 Avg Time Held
7.2
quarters
Top 20 Avg Time Held
8.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pediatrix Medical
MD
|
+$3.19M |
| 2 |
CELG
Celgene Corp
CELG
|
+$1.84M |
| 3 |
CVS Health
CVS
|
+$536K |
| 4 |
NVIDIA
NVDA
|
+$451K |
| 5 |
Walgreens Boots Alliance
WBA
|
+$377K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$2.26M |
| 2 |
Suncor Energy
SU
|
+$1.99M |
| 3 |
Pfizer
PFE
|
+$1.79M |
| 4 |
International Paper
IP
|
+$1.62M |
| 5 |
US Steel
X
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.29% |
| 2 | Financials | 19.28% |
| 3 | Healthcare | 18.76% |
| 4 | Miscellaneous | 9.36% |
| 5 | Consumer Discretionary | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.98T
| $10.1M | 6.93% |
256,808
+940
| +0.4% | +$45.6K |
2017 Q1
7 quarters
|
|
2
Microsoft
MSFT
$4.02T
| $9.64M | 6.59% |
94,916
-3,102
| -3% | -$332K |
2013 Q2
22 quarters
|
|
3
Merck
MRK
$359B
| $7.44M | 5.09% |
102,013
-1,545
| -1% | -$109K |
2013 Q2
22 quarters
|
|
4
SPDR Gold Trust
GLD
$141B
| $5.96M | 4.08% |
49,202
+940
| +2% | +$109K |
2013 Q2
22 quarters
|
|
5
TSMC
TSM
$2.3T
| $5.57M | 3.81% |
150,995
+38
| +0% | +$1.45K |
2014 Q3
17 quarters
|
|
6
ICICI Bank
IBN
$101B
| $5.01M | 3.43% |
486,776
-3,350
| -0.7% | -$31.6K |
2017 Q1
7 quarters
|
|
7
Amgen
AMGN
$226B
| $4.95M | 3.39% |
25,441
-195
| -0.8% | -$38K |
2017 Q1
7 quarters
|
|
8
Citigroup
C
$221B
| $4.94M | 3.38% |
94,964
-1,722
| -2% | -$109K |
2013 Q4
20 quarters
|
|
9
Intel
INTC
$536B
| $4.5M | 3.08% |
95,943
-2,392
| -2% | -$112K |
2016 Q2
10 quarters
|
|
|
TSS
10
DELISTED
Total System Services, Inc.
TSS
| $4.41M | 3.02% |
54,279
+196
| +0.4% | +$17.4K |
2017 Q2
6 quarters
|
|
11
Medtronic
MDT
$118B
| $4.18M | 2.86% |
45,937
+1,160
| +3% | +$108K |
2015 Q1
15 quarters
|
|
12
JPMorgan Chase
JPM
$889B
| $4.11M | 2.81% |
42,139
-787
| -2% | -$83.9K |
2013 Q2
22 quarters
|
|
13
Aptiv
APTV
$9.04B
| $4M | 2.74% |
64,999
-1,636
| -2% | -$119K |
2015 Q3
13 quarters
|
|
14
HSBC
HSBC
$323B
| $3.5M | 2.39% |
88,247
-5,028
| -5% | -$201K |
2017 Q2
6 quarters
|
|
15
Gilead Sciences
GILD
$187B
| $3.26M | 2.23% |
52,179
-2,287
| -4% | -$160K |
2017 Q3
5 quarters
|
|
16
Ecolab
ECL
$79.7B
| $3.22M | 2.2% |
21,856
-277
| -1% | -$42.3K |
2013 Q2
22 quarters
|
|
17
Tapestry
TPR
$23.4B
| $3.14M | 2.14% |
92,943
-31,346
| -25% | -$1.26M |
2017 Q4
4 quarters
|
|
|
LFC
18
DELISTED
China Life Insurance Company Ltd.
LFC
| $3.01M | 2.06% |
286,712
-1,379
| -0.5% | -$14.7K |
2014 Q1
19 quarters
|
|
19
Nike
NKE
$52.5B
| $2.78M | 1.9% |
37,451
-192
| -0.5% | -$14.4K |
2013 Q2
22 quarters
|
|
|
20
Pediatrix Medical
MD
$2.19B
| $2.62M | 1.79% |
+79,368
| New | +$3.19M |
2018 Q4
0 quarters
|
|
21
Biogen
BIIB
$33.9B
| $2.58M | 1.76% |
8,563
-471
| -5% | -$150K |
2017 Q4
4 quarters
|
|
22
ConocoPhillips
COP
$165B
| $2.41M | 1.65% |
38,619
-72
| -0.2% | -$4.9K |
2018 Q1
3 quarters
|
|
23
Berkshire Hathaway Class A
BRK.A
$1.11T
| $2.14M | 1.47% |
7
| – | – |
2017 Q1
7 quarters
|
|
24
Western Digital
WDC
$145B
| $2.03M | 1.39% |
72,713
-1,322
| -2% | -$46.8K |
2017 Q3
5 quarters
|
|
25
CSX Corp
CSX
$88.5B
| $1.97M | 1.35% |
95,322
-414
| -0.4% | -$9.52K |
2017 Q2
6 quarters
|
|
Similar funds
BMC
MCM
S
MIC
MJFG
DA
CSPIA
SMC
Augustine Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Augustine Asset Management held 83 positions worth $146M, down 19% from $181M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Augustine Asset Management withdrew a net $10.2M in Q4 2018, closing 8 positions and reducing 39 holdings. Its most notable exit was Pfizer, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Augustine Asset Management opened a new position in Pediatrix Medical worth $2.62M.
- Augustine Asset Management's largest Q4 2018 buy was Pediatrix Medical: 79,368 shares worth $2.62M.
- Augustine Asset Management added most to Enterprise Products Partners in Q4 2018, an estimated $165K increase.
- Augustine Asset Management's biggest Q4 2018 reduction was IBM, cutting an estimated $2.26M.
- Augustine Asset Management fully exited Pfizer in Q4 2018, selling an estimated $1.79M.
- Augustine Asset Management's ten largest holdings make up 43% of its $146M portfolio in Q4 2018.
- Augustine Asset Management opened 8 new positions and closed 8 in Q4 2018.
- Augustine Asset Management's portfolio value fell 19% quarter-over-quarter to $146M.
Based on Augustine Asset Management's 13F filing for Q4 2018, filed 6 Feb 2019.